Background/Aims: TASK channels belong to the two-pore-domain potassium (K 2P ) channel family. TASK-1 is discussed to contribute to chronic atrial fibrillation (AFib) and has been together with uncoupling protein 1 found as a marker protein of brown adipose tissue (BAT) fat. In addition, TASK-1 was linked in a genome-wide association study to an increased body mass index. A recent study showed that TASK-1 inhibition is causing obesity in mice by a BAT whitening and that these effects are linked to the mineralo corticoid receptor pathway, albeit the mechanism remained elusive. Therefore, we aimed to probe whether K 2P channels are regulated by serum-and glucocorticoid-inducible kinases (SGKs) which are known to modify many cellular functions by modulating ion channels. Methods: To this end we used functional co-expression studies and chemiluminescence-assays in Xenopus oocytes, together with fluorescence imaging and quantitative PCR experiments. Results: SGKs and proteinkinase B (PKB) induced a strong, dose-and time-dependent current reduction of TASK-1 and TASK-3.
Introduction
The mammalian K 2P channel family consists of 15 members of background or leak potassium channels, playing a crucial role in setting the resting membrane potential and thus regulating cellular excitability in many different cell types and tissues. TWIK-related acid-sensitive K + (TASK) channels belonging to the K 2P family of potassium channels are relevant for the pathogenesis of many different cardiovascular diseases [1, 2] , including pulmonary hypertension [3] , obstructive sleep apnea [4] and arrhythmias like atrial fibrillation (AFib) [4] [5] [6] or conduction disorders [7, 8] .
For instance TASK-1 channels are promising drug targets for the treatment of AFib, as they are upregulated under AFib [9, 10] and as these channels have the ability to modulate the human atrial action potential duration under normal and pathological conditions [5, 10] . As in humans TASK-1 lacks a ventricular expression [5] , a pharmacological inhibition of this channel can prolong atrial refractoriness and convert AFib, without causing life threatening ventricular side effects [4, 5] . On the other hand, the clinical benefit of a TASK-1 inhibition in AFib, in particular the putative side effect of pulmonary hypertension, is currently under debate [10] [11] [12] . Noteworthy, TASK-1 currents increased in chronic AFib patients much stronger than expected from transcriptional changes [10] , indicating an altered TASK-1 channel regulation during AFib.
TASK-1 has been reported to play a role in glucose-dependent insulin secretion of beta cells [13] . However, TASK-1 might not only be relevant for diabetes but also for obesity, two clinical entities often going hand in hand. Brown adipose tissue (BAT) is thought to protect against obesity, as its activation is causing a state of increased energy expenditure. However, the origin and molecular identity of BAT remained long time elusive. An RNA sequencing and unbiased genome-wide expression analyses approach recently identified TASK-1 (KCNK3) as a marker of BAT [14] . This study confirmed a previous report that the mitochondrial uncoupling protein (UCP1) together with KCNK3 are genetic markers of BAT, as in humans they are differentially expressed in BAT compared to white adipose tissue (WAT) [15] . Note that TASK1-like single channels were previously reported in rat BAT [16] , but also another K 2P channel, KCNK10, might be relevant in the context of obesity, as this channel plays a role in early stages of adipocyte differentiation [17] . Consistent with the identification of TASK-1 as a marker of BAT, a recent genome-wide association study (GWAS) identified an association of KCNK3 with an increased body mass index [18] . In addition, TASK-1 and UCP1 expression correlated in obese and cold-exposed mice [19] and most strikingly, TASK-1 knock-out mice are overweight because of an increase in WAT mass and BAT whitening [19] . It was concluded that TASK-1 controls the thermogenic activity in BAT, as a decreased oxygen consumption, UCP1 expression and lipolysis was evident under β 3 receptor stimulation. The TASK-1 blocker A293 or an activation of the mineralocorticoid pathway mimicked these effects, suggesting a link between TASK-1 and the mineralocorticoid receptor pathway. This link between TASK-1 and mineralocorticoid receptors was confirmed by the fact that addition of aldosterone to adipocytes of TASK-1 knock-out mice did not induce additional or increased effects [19] . Yet, it remained elusive how the mineralocorticoid pathway is mecha nistically coupled to TASK-1 channels. Interestingly, serum-and glucocorticoid-inducible kinase-1 (SGK1) is overexpressed in adipose tissue of subjects with obesity and diabetes [20] . Since SGK kinases are known regulators of ion channels, we started testing whether K 2P channels, in particular TASK-1, are regulated by these kinases; aiming to provide a link between the observed changes in SGK expression and the role of mineralocorticoids in brown tissue fat whitening.
SGK1 was initially identified in rat mammary tumor cells, where it was reported as an immediate early gene, with a transcription stimulated by serum and glucocorticoids [21] [22] [23] . SGKs belong to the family of AGC kinases and all three SGK family members share high amino acid homology to proteinkinase B (PKB) also known as Akt. SGK activity is under transcriptional control by numerous stimuli, including aldosterone [24] or the phosphorylation state. The canonical mechanism of activating all three SGK isoforms is the phosphatidylinositid-3-kinase (PI 3 K) pathway [25] . Activation of the pathway induces the production of phospatidyl-inositol-(3,4,5)-triphosphate (PIP 3 ) by PI 3 K. These lipids serve as plasma membrane docking sites for proteins that harbor pleckstrin-homology domains, including phospho inositide-dependent kinase 1 (PDK1) resulting in SGK phosphorylation. Additionally, PIP 3 leads to mTORC2 activation and SGK phosphorylation [26] . SGKs modify a variety of cellular functions either by a direct phosphorylation of ion channels and transporters, by phosphorylation of their regulating proteins or by transcriptional changes [24, [27] [28] [29] [30] [31] [32] [33] [34] . Strikingly, SGKs preferentially enhance the activity of ion channels and transporters by increasing the expression of the proteins at the plasma membrane [24] .
Using a functional co-expression screen, we found a preferential and unusual downregulation of the TASK-1 and TASK-3 channels. All three SGKs, but also the closely related PKB or PDK, which activate SGKs, reduced TASK-1 and TASK-3 current amplitudes by an internalization of the channels into late endosomes. Thus, stress mediated changes in SGK expression levels or altered SGK activation is likely to change TASK-1 and TASK-3 expression at the plasma membrane. This unusual downregulation of TASK-1 by SGKs is likely to contribute to the pathogenesis of chronic AFib and might provide a mechanistic link between increased mineralocorticoid levels and TASK-1 reduction, effects which were recently identified to be linked and to be responsible for brown tissue fat whitening.
Materials and Methods

Ethical approval
The investigation conforms to the guide for the Care and Use of laboratory Animals (NIH Publ. 85-23). Human tissue samples were obtained from the right atrial (RA) appendages. The study protocol was approved by the ethics committees of the University of Heidelberg (Germany; Medical Faculty Heidelberg, S-017/2013). Written informed consent was obtained from all patients, and the study was conducted in accordance with the Declaration of Helsinki.
Molecular biology
Human K 2P channel constructs (TASK-1, TASK-3, TASK-4, TRESK and TRAAK) and AS160 were cloned into the oocyte expression vector pSGEM. SGK-1, SGK-1 SD, SGK-2, SGK-3, SGK-3 SD, PKB and PDK constructs were used as previously described. For the chemi luminescence assay an hemagglutinin (HA)-epitope (YPYDVPDYA), preceded and followed by a proline-glycine-glycine linker, was inserted in the extracellular P2-M4 loop of rat TASK-1 at amino acid position 214 as previously described [35] . TASK-3 was cloned into pEGFP-C1 vector for imaging experiments.
Oocyte preparation, cRNA synthesis and cRNA injection Oocytes were obtained from anesthetized Xenopus laevis frogs and incubated in OR2 solution containing in mM: NaCl 82.5, KCl 2, MgCl 2 1, HEPES 5 (pH 7.5) substituted with 2 mg/ml collagenase II (Sigma) to remove residual connective tissue. Subsequently, oocytes were stored at 18 °C in ND96 solution supplemented with 50 mg/l gentamycine, 274 mg/l sodium pyruvate and 88 mg/l theophylline. All channels and kinases were subcloned into an oocyte expression vector and cDNA was linearized. cRNA was synthesized with mMESSAGE mMACHINE-Kit (Ambion). The quality of cRNA was tested using gel electrophoresis. Oocytes were each injected with 50 nl of cRNA. Individual oocytes were placed in 20 µl SuperSignal Elisa Femto solution (Pierce) and chemiluminescence was quantitated in a luminometer (Promega). The luminescence produced by non-injected oocytes was used as a reference signal (negative control).
Fluorescence microscopy
HeLa and COS-7 cells were grown to approximately 50 % confluence on glass cover slips in 35 mm Petri dishes (Nunc) using DMEM medium containing 10 % fetal bovine serum (Gibco/Thermo Fisher Scientific) + 1% penicillin/streptomycin (Gibco/Thermo Fisher Scientific). For live cell imaging cells were grown on 35 mm glass bottom Petri dishes (Willco). After 24 h, the cells were transfected using jetprime (Polyplus transfection) kit (Peqlab) following manufacture instructions with 0.2 µg pEGFP-C1 TASK3 or 1 µg pcDNA3.1 SGK1 together with 0.2 µg pEGFP-C1 TASK3. The cells were cultured at 37 °C for 6-36 h in an incubator supplied with 5 % CO 2 /95 % O 2 . Immunofluorescence and live cell imaging was performed utilizing a Zeiss imaging platform comprising an Axio Observer.Z1 microscope equipped with a Plan-Apochromat 60×/1.40 Oil DIC objective and a standard filter set for EGFP and DSRed (Zeiss 38HE). Digital images were taken with a 12 bit "AxioCam MRm" camera and processed using the AxioVision Software. For immunofluorescence experiments the cells were fixed with 4% PFA + 4% saccharose, permeabilized with 0.25% (v/v) Triton X-100 in PBS and stained with antibodies against late endosomes (CD63 1:200, Santa Cruz Biotechnology) and secondary Alexa 568 antibodies (1:200, Molecular Probes). Inhibition of endocytosis in Hela cells was carried out by incubation with the dynamin inhibitor dynasore (80 µM, Sigma) applied at least 4 hours after transfection.
Quantitative real-time PCR
Quantitative real-time PCR (RT-qPCR) was performed using the StepOnePlus (Applied Biosystems, Foster City, CA, USA). Total RNA was prepared using TRIzol-Reagent (Invitrogen, Karlsruhe, Germany) according to the manufacturer's instructions. Complementary DNA synthesis was carried out with the Maxima First Strand cDNA Synthesis Kit for RT-qPCR (Thermo Fisher Scientific, Waltham, MA, USA) using 3 µg of total RNA. 96 well optical detection plates (Applied Biosystems, Foster City, CA, USA) were then loaded to a total volume of 10 µl per well, consisting of 0.5 µl cDNA, 5 µl TaqMan Fast Universal Master Mix (Applied Biosystems), and 6-carboxyfluorescein (FAM)-labeled TaqMan probes and primers (TaqMan Gene Expression Assays; Applied Biosystems). In addition, pre-designed primers and probes detecting importin 8 (IPO8) were used for normalization. All RT-qPCR reactions were performed in triplicate, and control experiments in the absence of cDNA were included. Data are expressed as an average of triplicates. Primers with the following Accession numbers were used: IPO8 (Importin 8), Hs00183533_m1; SGK1, Hs00178612_ m1; SGK2, Hs00367639_m1; SGK3, Hs00993639_m1.
Data analyses
Results are reported as mean ± SEM (n = number of oocytes). Statistical differences were evaluated by Student's unpaired t-test. Significance was assumed for p<0.05, indicated in the figures by an asterisk (*), p<0.01, by two asterisk (**), p<0.001 by three asterisk (***) or by "n.s." for non-significant changes.
Results
SGKs, PKB and PDK reduce TASK-1 and TASK-3 currents
To probe for a regulation of K 2P channels by SGKs, we performed co-expression experiments in Xenopus laevis oocytes (Fig. 1) . Here, co-expression of SGK2 did not affect TASK-4, TRESK and TRAAK currents amplitudes, while it caused a pronounced reduction of currents encoded by the acid-sensitive K 2P channels TASK-1 and TASK-3 (Fig. 1A, B) . To test for a putative inhibition of TASK-1 and TASK-3 currents by the other SGK isoforms and Cellular Physiology and Biochemistry
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by PKB, sharing high homology to SGK2, these kinases were individually co-expressed with TASK-1 and TASK-3 in Xenopus oocytes. All kinases shared the ability to strongly reduce the current amplitudes of both, TASK-1 ( Fig. 2A ) and TASK-3 ( Fig. 2B) , albeit with different efficiencies. For both TASK channels, SGK2 provoked the most pronounced current reduction of all SGK isoforms tested. PDKs are known to phosphorylate and thereby activate SGKs. PDK was co-injected with TASK-1 or TASK-3 ( Fig. 2A, B) . PDK causes a current reduction of both channels, most probably indirectly via an activation of endogenous SGKs since TASK-1/3 
do not contain PDK phosphorylation consensus sites. In addition, we co-expressed TASK-1 or TASK-3 with dominant active SGK constructs, SGK1 S422D (SGK1 SD) and SGK3 S356D (SGK3 SD), mimicking SGK phosphorylation in its C-terminus, thereby activating the kinases. The co-expression of both, SGK1 SD and SGK3 SD, led to an even more pronounced reduction of TASK-1 (Fig. 2C) as well as for TASK-3 (Fig. 2D) .
SGK-2 effect on TASK-3 is time and dose dependent
SGK kinases almost exclusively increase the surface expression of many ion channels and transporters, albeit by distinct mechanism. Surprisingly, in this study we noticed a current reduction of the K 2P channels TASK-1 and TASK-3 via SGK kinases, PKB and PDK. Hence, we studied a potential dose and time dependence of the effect. For this purpose different cRNA ratios (1:1, 1:10, 1:100 and 1:500) of TASK-3 and SGK2 were co-expressed in oocytes and current amplitudes were measured at different time points after injection (24 h, 48 h and 72 h) (Fig. 3) . Here, small amounts of SGK2 (1:1 to 1:10 ratio of channel to kinase) led to a current increase after 24 and 48 h, whereas the presence of more SGK2, similar as utilized in the initial search for modulated K 2P channels, or recordings at later time points (72 h), led to a current reduction. After 72 h all ratios tested resulted in a TASK-3 current reduction. In conclusion, TASK-3 down regulation seemed to be concentration and time dependent.
SGK reduces the surface expression of TASK-1/3 channels
In order identify the underlying mechanism leading to changes in channel amplitudes, we quantified the surface expression of TASK-1 after SGK2 co-expression. For this purpose an Performing an ELISA based chemilumi nescence assay, co-expression of SGK-2 (1:500) caused a reduction of the TASK-1 surface expression (Fig. 4A ). In addition, we performed live cell imaging in COS-7 cells transfected with TASK-3 pEGFP alone or together with SGK-1. After 24 h, in the presence of SGK-1, TASK-3 was hardly detected at the plasma membrane and a dotted, presumably endosomal pattern was observed (Fig. 4B) . Thus, SGKs may regulate trafficking of TASK-3, leading to an increased fraction of intracellular channel protein.
TASK-3 co-localizes with the late endosome marker CD63
To gain further insights into the intracellular localization of TASK-3 in the presence of SGK1, we transfected HeLa cells with TASK-3 pEGFP alone or together with SGK1. Cells were fixed 24 h after transfection and stained with the late endosomal marker CD63 (Fig. 5) . These experiments showed that SGK1 co-expression leads to a more pronounced endosomal TASK-3 localization, indicated by the co-localization with CD63 (Fig. 5F ). Furthermore, time line experiments in HeLa cells showed that 12 hours after transfection TASK-3 is already reaching the surface membrane, while TASK-3 co-expressed with SGK1 was still predominantly localized in cytoplasmatic vesicles (for all online suppl. material, see www. karger.com/doi/10.1159/000485402, Suppl. Fig. 1B, F) . After 24h of incubation TASK-3 is strongly expressed at the plasma membrane, while TASK-3 co-expressed with SGK1 showed a clearly reduced surface expression and many vesicles around the nuclei (see online suppl. material, Suppl. Fig. 1C, G) . After 36 hours TASK-3 still predominantly localized to the plasma membrane, while co-expression with SGK1 apparently retrieved the channels to vesicles in the perinuclear area (see online suppl. material, Suppl. Fig. 1D, H) .
TASK-3, in the presence of SGK2, is internalized via a Rab4-and Rab5-dependent pathway
We observed that co-expression of TASK-1 and TASK-3 with SGKs leads to a rapid current reduction, especially using higher concentrations of SGKs (Fig. 3A) . Thus, we speculated that the channels, in order to reach the late endosomal compartment, are quickly intern alized by an early endosomal pathway. To challenge this question, TASK-3 together with SGK2 was co-expressed with either a wild-type Rab or its dominant-negative construct (Fig. 6A, B) . Inhibition of early endocytosis with dominant-negative Rab4 or dominant-negative Rab5 increases TASK-3 current amplitudes (Fig. 6A, B) . This data indicates that TASK-3 is in the presence of SGK2 endocytosed via a Rab4 and Rab5 dependent early endocytosis pathway.
The SGK mediated reduction of TASK-3 surface expression is antagonized by blocking clathrin-mediated endocytosis
Dynasore blocks dynamin and is a specific and highly effective blocker of clathrinmediated endocytosis. In this study, we applied dynasore (80 µM) after transfecting HeLa cells with TASK-3 alone or together with SGK1. Similar as described above (see online suppl. material, Suppl. Fig. 1C, G) , 24 hours after transfecting TASK-3 together with SGK1, the channel was located at the surface membrane, albeit with a reduced efficiency (Fig. 7A, B) , which also becomes evident by the less pronounced formation of filopodia ( Fig. 7B and see online suppl. material, Suppl. Fig. 1G ). Strikingly, when cells co-transfected with TASK-3 and SGK1 in the presence of dynasore, we observed a massive increase in fluorescence at the plasma membrane and a pronounced formation of filopodia, confirming that the current reduction of TASK-3 by SGKs is mediated by endocytosis.
Putative interaction partners mediating the indirect effect of SGKs and PKB on TASK-1/3?
Since TASK-1 and TASK-3 do not contain consensus motifs for SGK or PKB phosphorylation, the observed TASK channel regulation must be indirect in nature. Several mechanisms for an indirect ion channel regulation via SGKs are described including the involvement of Nedd4-2, NHERF2, PIKfyve, AS160 or 14-3-3. Since TASK-1 and TASK-3 surface expression is Cell
regulated in a 14-3-3 dependent manner, we tested whether AS160 might be involved in the observed effects. AS160 has been described as Akt Substrate with 160 kilodalton (AS160), as it is phosphorylated by PKB. Phosphorylation of AS160 by PKB (Akt) or SGKs will lead to a binding of 14-3-3 which might interfere with an efficient TASK-1/3 surface expression. Coinjection of AS160 with TASK-3 resulted in a similar current decrease as the co-injection of small amounts of SGK2 (see online suppl. material, Suppl. Fig. 2 ). Moreover, co-expression of both, small amounts of SGK2 and AS160, led to an even more pronounced TASK-3 current reduction. However, 14-3-3 is known to regulate forward trafficking of TASK-1 and TASK-3 and not channel endocytosis. Thus, despite some evidence for the involvement of AS160 in TASK channel regulation, the complete pathway and mediators of the indirect TASK channel modulation by SGKs currently remain elusive (Fig. 8) .
Decreased expression of SGK1 and SGK2 in atrial cardiomyocytes of patients with chronic AF might contribute to increased TASK-1 currents
TASK-1 is a promising target for the treatment and prevention of AFib. Previously an up-regulation of TASK-1 was observed under chronic AFib that might contribute to the pathogenesis of this common arrhythmia. Surprisingly, the TASK-1 currents recorded from atrial cardiomyocytes from patients with chronic AFib were increased more than expected by the transcriptional changes in mRNA and the resulting protein levels. This effect was not present in patients with paroxysmal AFib. Using quantitative PCR experiments we analyzed changes in the mRNA expression of SGK1-3 in atrial cardiomyocytes of control probands compared to patients with paroxysmal and chronic AFib (Fig. 9 and see online suppl. material, Suppl. Fig. 3 ). In atrial cardiomyocytes of patients with chronic AFib we observed decreased expression levels of SGK1 and SGK2 which were not present in patients with paroxysmal AFib. The reduced expression levels of SGK1 and SGK2 might contribute to the pronounced increase in TASK-1 currents typical for chronic AFib, as reduced SGK levels are likely to increase the surface expression of TASK-1 and TASK-3. 
Discussion
We have observed that SGKs cause a strong reduction of TASK-1 and TASK-3 currents, by a reduced number of channels at the plasma membrane, as shown with voltage clamp recordings in combination with an ELISA-based chemiluminescence assay. All SGK isoforms as well as PKB shared the ability to reduce the current amplitudes of both TASK-1 and TASK-3. Fluorescence imaging experiments revealed that in the presence of SGK1, TASK-3 was only weakly expressed at the plasma membrane and that SGK1 co-expression leads to a predominant localization of TASK-3 channels in an endosome-like compartment. The down regulation of TASK-3 was abolished by the dynamin inhibitor dynasore, suggesting a role of SGK in TASK channel endocytosis. TASK-1 and TASK-3 have no consensus sequence predicting a SGK phosphorylation site. Thus, an indirect modulation by SGKs is likely and several mechanisms for such an indirect regulation were previously described [36] [37] [38] [39] [40] [41] [42] [43] [44] . Substrates mediating effects by SGKs include for example PIKfyve, AS160, Nedd4-2, NHERF2 or 14-3-3 [45] [46] [47] . Interestingly, TASK channels are regulated via 14-3-3 enhancing channel surface expression. Since besides TASK-1 and TASK-3 none of the tested K 2P channels is sensitive to SGKs and 14-3-3 [35, 48, 49] , it may be possible that the SGK effects are mediated by 14-3-3 and the Rab protein regulator AS160. In the case of the epithelial sodium channel, ENaC, Liang et al. [47] showed that an aldosterone induced phosphor ylation of AS160 at its SGK1 phosphor ylation sites, evoked a binding of AS160 to the steroid-induced 14-3-3 isoforms β and ε [47] . This interaction of AS160 with 14-3-3β and ε was blocked by mutations at the SGK1 phosphor ylation sites, suppressing the ability of AS160 to augment aldosterone action on ENaC [47] . In our experiments AS160 co-expression led to reduced TASK-3 currents which was even more pronounced in the presence of SGK2. Thus, AS160 phosphorylation by SGKs may evoke 14-3-3 binding or scavenging 14-3-3 which is however required for TASK forward transport. On the other hand our experiments clearly identified an increased endocytosis of TASK channels and do not point towards an altered forward transport. Thus, the precise mechanism of the indirect regulation of TASK channels and the substrates mediating these SGK effects currently remain elusive and include a plethora of putative pathways (Fig. 8) . Since SGKs almost exclusively increase the surface expression of ion channels and transporters, the effect of an increased endocytosis of TASK-1 and TASK-3 channels might obey an unusual or not yet identified novel pathway. Thus, identifying the precise trafficking mechanisms and partners will require independent and intensive future studies.
During AFib KCNK3 (TASK-1) is transcript ional ly upregulated [9, 10] , an effect which we have also observed in our hands (not published). In a study by Schmidt et al., TASK-1 is upregulated in atrial cardiomyoyctes of patients with chronic AFib by a factor of 1.6 on mRNA and protein level [10] . However, the TASK-1 currents recorded from atrial cardiomyocytes of these patients increased much stronger (3-fold), resulting in shortened action potentials in patients with chronic AFib. As the TASK-1 currents increased much stronger than expected by the changes on mRNA and protein level it suggested an altered regulation of TASK-1 
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Cellular Physiology and Biochemistry surface expression or gating during AFib. The transcript ional downregulation of SGK1 and SGK2 in the atria of patients with chronic AFib that we have found in our current study may explain the unexpectedly pronounced increase in TASK-1 current amplitudes during AFib (Fig. 10A ). This effect however might be an important factor contributing to the electrical remodeling and chronification of AFib by increased TASK-1 currents and enhanced rates of repolarization. TASK-1 knock-out mice are overweight due to an increase in WAT mass and a BAT whitening [19] . It was found that TASK-1 controls the thermogenic activity in BAT and that TASK-1 blockers or mineralocorticoids mimic these effects. Although the link between TASK-1 and mineralocorticoid receptors was impressively elaborated and confirmed, i.e. by the fact that aldosterone cannot induce effects in adipocytes of the TASK-1 knock-out mice [19] , the mechanism of this functional coupling remained elusive. According to our new data, increased mineralo corticoid levels should stimulate SGKs in adipocytes leading to a reduction of functional TASK-1 currents at the plasma membrane, similar as in the genetic mouse model or by A293, providing the missing mechanistic link for the BAT whitening observed by decreasing TASK-1 expression or increasing mineralocorticoid levels (Fig. 10B ). This hypothesis is further supported by the fact that SGK1 is overexpressed in adipose tissue of subjects with obesity and diabetes [20] .
Patients with type 2 diabetes have increased insulin levels, resulting in an upregulation of the PI 3 -kinase-pathway which is thought to cause cardiac repolarization abnormalities and arrhythmias [50] . An upregulation of the PI 3 -kinase-pathway will also result in an activation of SGKs and might cause a reduction of TASK channels. Therefore, these effects might contribute to cardiac arrhythmias and the obesity observed in diabetes. For diabetes this would reflect a circulus vitiosus, as obesity is involved in the development of the hyperinsulinism.
Summarizing we hypothesize that stress-mediated changes in SGK expression pattern or activation is likely to alter TASK-1 and TASK-3 expression at the plasma membrane. The down regulation of TASK-1 by SGKs is likely to contribute to the pathogenesis of chronic AFib and provides a mechanistic link between increased mineralocorticoid levels and the TASK-1 reduction responsible for brown tissue fat whitening. As TASK-1 channels appear to be involved in the pathogenesis of many diseases, including obstructive sleep apnea and pulmonary hypertension, it is promising to study the stress-kinase dependent regulation of these channels in different pathophysiological settings. illustrates that the TASK-1 current increase in chronic AFib might occur in a synergistic manner by a transcriptional upregulation and by increasing the number of channels at the surface membrane, due to reduced SGK1 and SGK2 expression levels. (B), The cartoon illustrates that a pharmacological and a genetic block of TASK-1 leads to a brown tissue fat whitening which is linked to an activation of the mineralocorticoid receptor pathway, albeit with a yet unclear mechanism (?). We propose that the mechanistic link between mineralocorticoid receptor pathway stimulation and TASK-1 inhibition in brown tissue fat whitening is reflected by the SGK dependent inhibition of TASK-1.
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